📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Co-inhibition of TGF-ß and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance (2024)

First Author: Nair R

Attributed to: Molecular mechanisms enabling cDC2s to control Th2 cell priming funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2024.2330194

Publication URI: http://dx.doi.org/10.1080/2162402x.2024.2330194

Type: Journal Article/Review

Parent Publication: OncoImmunology

Issue: 1